Efficiency of benzydamine use in treatment of URTI (including COVID-19) in child patients

Close metadata

THE AIM

Share with healthcare practitioners personal experience of using benzydamine spray (Oralsept) in pediatric practice; present a clinical case, which, according to the author, can help doctors optimize approaches to the treatment of patients with acute respiratory viral infections (including COVID-19), thereby improving the quality of life of pediatric patients.

Keywords:

ARVI (acute respiratory viral infection)

COVID-19

clinical case

pain

diarrhea

benzydamine

Oralcept

Authors:

Davydova A.N.

Volgograd State Medical University

Received:

20.07.2022

Accepted:

13.09.2022

List of references:

Klinicheskie rekomendacii. Ostraya respiratornaya virusnaya infekciya (ORVI). Vozrastnaya gruppa: deti. Soyuz pediatrov Rossii. Evro-Aziatskoe obshchestvo po infekcionnym boleznyam; 2021. Accessed September 25, 2022. (In Russ.). https://www.pediatr-russia.ru/information/klin-rek/proekty-klinicheskikh-rekomendatsiy.pdf
Metodicheskie rekomendacii. Osobennosti klinicheskih proyavlenij i lecheniya zabolevaniya, vyzvannogo novoj koronavirusnoj infekciej (COVID-19) u detej. Versiya 2 (03.07.20). Ministerstvo zdravoohraneniya Rossijskoj Federacii; 2020. Accessed September 25, 2022. (In Russ.). https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_%D0%B4%D0%B5%D1%82%D0%B8_COVID-19_v2.pdf
Federal’naya sluzhba po nadzoru v sfere zashchity prav potrebitelej i blagopoluchiya cheloveka. Accessed 27.09.2021. https://www.rospotrebnadzor.ru/
Tsarkova SA, Moroz GA, Birulya NI. Assessment of the possibility of introducing an international protocol for the management of children with enteroviral vesicular stomatitis at the outpatient stage of pediatric care. RMZh. 2018;(9):17-19. (In Russ.).
Corsino CB, Ali R, Linklater DR. Herpangina. [Updated 2021 May 7]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Accessed 06.08.2021. https://www.ncbi.nlm.nih.gov/books/NBK507792/
Yao X, Bian LL, Lu WW, Li JX, Mao QY, Wang YP, Gao F, Wu X, Ye Q, Li XL, Zhu FC, Liang Z. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014. Human Vaccines and Immunotherapeutics. 2017;13(4):823-830. https://doi.org/10.1080/21645515.2016.1236879
Miyazawa I, Azegami Y, Kasuo S, Yoshida T, Kobayashi M, Shiraishi T. Prevalence of enterovirus from patients with herpangina and hand, foot and mouth disease in Nagano Prefecture, Japan, 2007. Japanese Journal of Infectious Diseases. 2008;61(3):247-248.
Ceylan AN, Turel O, Gultepe BS, Inan E, Turkmen AV, Doymaz MZ. Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6: A Preliminary Report from Istanbul. Polish Journal of Microbiology. 2019;68(2):165-171. https://doi.org/10.21307/pjm-2019-016
Arkhipina SA, Grinishina EA. Clinical and epidemiological analysis of cases of enterovirus infection in the oryol region in adults. Klinicist. 2020;14(3-4):52-56. (In Russ.). https://doi.org/10.17650/1818-8338-2020-14-3-4-K616
Mezhdunarodnaya klassifikaciya boleznej 10 peresmotra (oficial’nyj sajt). Accessed 06.08.21. https://icd.who.int/browse10/2019/en#/B00-B09/
Ceylan AN, Turel O, Gultepe BS, Inan E, Turkmen AV, Doymaz MZ. Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6: A Preliminary Report from Istanbul. Polish Journal of Microbiology. 2019;68(2):165-171. https://doi.org/10.21307/pjm-2019-016
Keawcharoen J. Hand, Foot, and Mouth Disease. Thai Journal of Veterinary Medicine. 2012;42(3):255-257.
Gosudarstvennyj reestr lekarstvennyh sredstv Minzdrava Rossii. Accessed 07.07.22. (In Russ). https://grls.rosminzdrav.ru/
Sironi M, Milanese C, Vecchi A, Polenzani L, Guglielmotti A, Coletta I, Landolfi C, Soldo L, Mantovani A, Pinza M. Benzydamine inhibits the release of tumor necrosis factor-alpha and monocyte chemotactic protein-1 by Candida albicans-stimulated human peripheral blood cells. International Journal of Clinical and Laboratory Research. 1997;27(2):118-122. https://doi.org/10.1007/bf02912445
Modéer T, Yucel-Lindberg T. Benzydamine reduces prostaglandin production in human gingival fibroblasts challenged with interleukin-1 beta or tumor necrosis factor alpha. Acta Odontologica Scandinavica. 1999;57(1):40-45. https://doi.org/10.1080/000163599429093
Chernyshova O.E. A rational approach to the treatment of acute tonsillopharyngitis in children. Zdorov’e rebenka. 2016;7(75):72-79. (In Russ.).
Savlevich EL, Doroschenko NE, Slavinskaya IS, Farikov SE. Important factors of the inflammatory process in the o ropharynx and optimal treatment regimes selection. Meditsinskiy sovet. 2017;(16):48-54. (In Russ.). https://doi.org/10.21518/2079-701X-2017-16-48-54
Quane PA, Graham GG, Ziegler JB. Pharmacology of benzydamine. Inflammopharmacology. 1998;6(2):95-107. https://doi.org/10.1007/s10787-998-0026-0
Lang DH, Rettie AE. In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms. British Journal of Clinical Pharmacology. 2000;50(4):311-314. https://doi.org/10.1046/j.1365-2125.2000.00265.x
Shakhtel BP, Padjarino DA. A randomized, double-blind, placebo-controlled model demonstrating the local effect of benzydamine in children with tonsillopharyngitis. Zdorov`e rebenka. 2012;8(43):73-76. (In Russ.).
Whiteside MW. A controlled study of benzydamine oral rinse («Difflam») in general practice. Current Medical Research and Opinion. 1982;8(3):188-190. https://doi.org/10.1185/03007998209112381
Shakespeare V, Shakespeare PG, Evans BT. Effects of proprietary oral rinses containing chlorhexidine, hexetidine and benzydamine on the proliferation of human buccal epithelial cells in culture. Archives of Oral Biology. 1988;33(12):881-885. https://doi.org/10.1016/0003-9969(88)90017-9
Alsohime F, Temsah MH, Al-Nemri AM, Somily AM, Al-Subaie S. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome. Journal of Infection and Public Health. 2020;13(12):1791-1796. https://doi.org/10.1016/j.jiph.2020.10.00
Yasuhara J, Kuno T, Takagi H, Sumitomo N. Clinical characteristics of COVID-19 in children: A systematic review. Pediatric Pulmonology. 2020;55(10):2565-2575. https://doi.org/10.1002/ppul.24991
Poryadok vedeniya detej s ostrymi respiratornymi infekciyami, v tom chisle COVID-19, nahodyashchihsya na ambulatornom lechenii v medicinskih organizaciyah gosudarstvennoj sistemy zdravoohraneniya goroda Moskvy. Pod red. Hripuna A.I. M.: GBU «NIIOZMM DZM»; 2021. (In Russ.).
Pereverzev AP, Pereverzeva AS, Popadyuk VI, Ostroumova OD. Herpangina. Clinical case. Vestnik otorinolaringologii. 2021;86(5):97-102. (In Russ.).

Close metadata